Literature DB >> 18941394

A review of current evidence-based clinical applications for breast magnetic resonance imaging.

Wendy DeMartini1, Constance Lehman.   

Abstract

Magnetic resonance imaging (MRI) is an important new tool for imaging of the breast. MRI has now been demonstrated to be the most sensitive imaging method for detecting breast carcinoma, allowing depiction of cancers that are occult on mammography, ultrasound, and clinical breast examination. This is tempered by imperfect specificity due to overlap in the features of benign and malignant lesions, and by higher examination cost and more limited availability compared to other breast imaging tests. This article describes the current evidence-based clinical indications for use of breast MRI. Specifically, MRI has been shown to be advantageous for cancer assessment for screening patients at high risk, evaluating patients with a new breast cancer diagnosis, monitoring patients undergoing neoadjuvant chemotherapy, and evaluating patients with metastatic axillary adenocarcinoma and unknown primary site. This tool has also been shown to be useful for the evaluation of silicone breast implant integrity. Employment of breast MRI as a problem solving technique for equivocal mammographic or clinical findings is controversial. For each of these clinical applications, the evidence regarding the diagnostic accuracy of breast MRI will be reviewed. An understanding of the current evidence will facilitate the most appropriate utilization of this important medical resource.

Entities:  

Mesh:

Year:  2008        PMID: 18941394     DOI: 10.1097/RMR.0b013e31818a40a5

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  31 in total

Review 1.  Principles and methods for automatic and semi-automatic tissue segmentation in MRI data.

Authors:  Lei Wang; Teodora Chitiboi; Hans Meine; Matthias Günther; Horst K Hahn
Journal:  MAGMA       Date:  2016-01-11       Impact factor: 2.310

2.  Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T.

Authors:  K Pinker; W Bogner; P Baltzer; S Trattnig; S Gruber; O Abeyakoon; M Bernathova; O Zaric; P Dubsky; Z Bago-Horvath; M Weber; D Leithner; T H Helbich
Journal:  Eur Radiol       Date:  2013-12-05       Impact factor: 5.315

3.  Impact of Henda's law on the utilization of screening breast magnetic resonance imaging.

Authors:  Callan Mason; Kendall Yokubaitis; Evan Howard; Zeeshan Shah; Jean Wang
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-01

4.  Accuracy of diffusion kurtosis imaging in characterization of breast lesions.

Authors:  Alexandra Christou; Abraham Ghiatas; Dimitrios Priovolos; Konstantia Veliou; Haralambos Bougias
Journal:  Br J Radiol       Date:  2017-04-06       Impact factor: 3.039

5.  Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices.

Authors:  Christoph I Lee; Laura Ichikawa; Michele C Rochelle; Karla Kerlikowske; Diana L Miglioretti; Brian L Sprague; Wendy B DeMartini; Karen J Wernli; Bonnie N Joe; Bonnie C Yankaskas; Constance D Lehman
Journal:  Acad Radiol       Date:  2014-08-07       Impact factor: 3.173

Review 6.  Optical tomography of breast cancer-monitoring response to primary medical therapy.

Authors:  Louise C Enfield; Adam P Gibson; Jeremy C Hebden; Michael Douek
Journal:  Target Oncol       Date:  2009-09-24       Impact factor: 4.493

7.  Algorithm-based method for detection of blood vessels in breast MRI for development of computer-aided diagnosis.

Authors:  Muqing Lin; Jeon-Hor Chen; Ke Nie; Daniel Chang; Orhan Nalcioglu; Min-Ying Su
Journal:  J Magn Reson Imaging       Date:  2009-10       Impact factor: 4.813

Review 8.  Multiparametric MR Imaging of Breast Cancer.

Authors:  Habib Rahbar; Savannah C Partridge
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

9.  Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition.

Authors:  Sanaz A Jansen; Akiko Shimauchi; Lindsay Zak; Xiaobing Fan; Abbie M Wood; Gregory S Karczmar; Gillian M Newstead
Journal:  AJR Am J Roentgenol       Date:  2009-09       Impact factor: 3.959

10.  Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.

Authors:  J Dose-Schwarz; R Tiling; S Avril-Sassen; S Mahner; A Lebeau; C Weber; M Schwaiger; F Jänicke; M Untch; N Avril
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.